Tatva Chintan Pharma Chem Limited (NSE:TATVA)

Tatva Chintan Pharma Chem Revenue

In the fiscal year ending March 31, 2026, Tatva Chintan Pharma Chem had annual revenue of 5.06B INR with 32.18% growth. Tatva Chintan Pharma Chem had revenue of 1.34B in the quarter ending March 31, 2026, with 24.36% growth.

• Revenue: 5.06B
• Revenue Growth: +32.18%
• P/S Ratio: 5.24
• Revenue / Employee: 7.45M
• Employees: 679
• Market Cap: 26.51B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	5.06B	1.23B	32.18%
Mar 31, 2025	3.83B	-107.90M	-2.74%
Mar 31, 2024	3.94B	-301.08M	-7.11%
Mar 31, 2023	4.24B	-100.35M	-2.31%
Mar 31, 2022	4.34B	1.33B	44.38%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 28, 2026

Data Sources Report a data error